Drug attitude in adolescents: A key factor for a comprehensive assessment

Silvia Molteni, Giovanni Giaroli, Giorgio Rossi, Mario Comelli, Maneesh Rajendraprasad, Umberto Balottin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

OBJECTIVE: Very few studies have evaluated the subjective experience (SE) in children and adolescents treated with antipsychotics. The present study aimed to evaluate the SE of antipsychotics in adolescents diagnosed with different psychiatric conditions and to identify explanatory variables of adolescents' SE and compliance with treatment. METHODS: The Drug Attitude Inventory (DAI) was used to evaluate SE in 67 adolescents in 2 different countries (Italy and United Kingdom). Compliance was measured using a Likert scale completed by both patients and parents. To evaluate other parameters correlated to the SE, the following scales were administered: Clinical Global Impression Scale, Children's Global Assessment Scale, Extrapyramidal Symptoms Rating Scale, Barnes Akathisia Rating Scale, and EuroQoL (for quality of life). Multiple and logistic regression analyses were applied. RESULTS: No significant difference in drug attitude was found between psychotic and nonpsychotic patients. Our results showed a highly significant association between DAI and compliance (Spearman index, 0.33; P = 0.005); for all other variables, DAI associated significantly only with quality of life (r = 0.25; P = 0.03). The multivariable analysis confirmed the presence of a strong association between compliance and DAI (P =

Original languageEnglish
Pages (from-to)99-108
Number of pages10
JournalJournal of Clinical Psychopharmacology
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Compliance
Equipment and Supplies
Pharmaceutical Preparations
Antipsychotic Agents
Quality of Life
Psychomotor Agitation
Italy
Psychiatry
Parents
Logistic Models
Regression Analysis
Therapeutics
United Kingdom

Keywords

  • Adolescence
  • Antipsychotic drugs
  • Compliance
  • Drug Attitude Inventory (DAI)
  • Psychosis
  • Subjective experience

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Drug attitude in adolescents : A key factor for a comprehensive assessment. / Molteni, Silvia; Giaroli, Giovanni; Rossi, Giorgio; Comelli, Mario; Rajendraprasad, Maneesh; Balottin, Umberto.

In: Journal of Clinical Psychopharmacology, Vol. 34, No. 1, 02.2014, p. 99-108.

Research output: Contribution to journalArticle

Molteni, Silvia ; Giaroli, Giovanni ; Rossi, Giorgio ; Comelli, Mario ; Rajendraprasad, Maneesh ; Balottin, Umberto. / Drug attitude in adolescents : A key factor for a comprehensive assessment. In: Journal of Clinical Psychopharmacology. 2014 ; Vol. 34, No. 1. pp. 99-108.
@article{c55e2ddc57de42ae99a5ad9c570bc08e,
title = "Drug attitude in adolescents: A key factor for a comprehensive assessment",
abstract = "OBJECTIVE: Very few studies have evaluated the subjective experience (SE) in children and adolescents treated with antipsychotics. The present study aimed to evaluate the SE of antipsychotics in adolescents diagnosed with different psychiatric conditions and to identify explanatory variables of adolescents' SE and compliance with treatment. METHODS: The Drug Attitude Inventory (DAI) was used to evaluate SE in 67 adolescents in 2 different countries (Italy and United Kingdom). Compliance was measured using a Likert scale completed by both patients and parents. To evaluate other parameters correlated to the SE, the following scales were administered: Clinical Global Impression Scale, Children's Global Assessment Scale, Extrapyramidal Symptoms Rating Scale, Barnes Akathisia Rating Scale, and EuroQoL (for quality of life). Multiple and logistic regression analyses were applied. RESULTS: No significant difference in drug attitude was found between psychotic and nonpsychotic patients. Our results showed a highly significant association between DAI and compliance (Spearman index, 0.33; P = 0.005); for all other variables, DAI associated significantly only with quality of life (r = 0.25; P = 0.03). The multivariable analysis confirmed the presence of a strong association between compliance and DAI (P =",
keywords = "Adolescence, Antipsychotic drugs, Compliance, Drug Attitude Inventory (DAI), Psychosis, Subjective experience",
author = "Silvia Molteni and Giovanni Giaroli and Giorgio Rossi and Mario Comelli and Maneesh Rajendraprasad and Umberto Balottin",
year = "2014",
month = "2",
doi = "10.1097/JCP.0000000000000035",
language = "English",
volume = "34",
pages = "99--108",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Drug attitude in adolescents

T2 - A key factor for a comprehensive assessment

AU - Molteni, Silvia

AU - Giaroli, Giovanni

AU - Rossi, Giorgio

AU - Comelli, Mario

AU - Rajendraprasad, Maneesh

AU - Balottin, Umberto

PY - 2014/2

Y1 - 2014/2

N2 - OBJECTIVE: Very few studies have evaluated the subjective experience (SE) in children and adolescents treated with antipsychotics. The present study aimed to evaluate the SE of antipsychotics in adolescents diagnosed with different psychiatric conditions and to identify explanatory variables of adolescents' SE and compliance with treatment. METHODS: The Drug Attitude Inventory (DAI) was used to evaluate SE in 67 adolescents in 2 different countries (Italy and United Kingdom). Compliance was measured using a Likert scale completed by both patients and parents. To evaluate other parameters correlated to the SE, the following scales were administered: Clinical Global Impression Scale, Children's Global Assessment Scale, Extrapyramidal Symptoms Rating Scale, Barnes Akathisia Rating Scale, and EuroQoL (for quality of life). Multiple and logistic regression analyses were applied. RESULTS: No significant difference in drug attitude was found between psychotic and nonpsychotic patients. Our results showed a highly significant association between DAI and compliance (Spearman index, 0.33; P = 0.005); for all other variables, DAI associated significantly only with quality of life (r = 0.25; P = 0.03). The multivariable analysis confirmed the presence of a strong association between compliance and DAI (P =

AB - OBJECTIVE: Very few studies have evaluated the subjective experience (SE) in children and adolescents treated with antipsychotics. The present study aimed to evaluate the SE of antipsychotics in adolescents diagnosed with different psychiatric conditions and to identify explanatory variables of adolescents' SE and compliance with treatment. METHODS: The Drug Attitude Inventory (DAI) was used to evaluate SE in 67 adolescents in 2 different countries (Italy and United Kingdom). Compliance was measured using a Likert scale completed by both patients and parents. To evaluate other parameters correlated to the SE, the following scales were administered: Clinical Global Impression Scale, Children's Global Assessment Scale, Extrapyramidal Symptoms Rating Scale, Barnes Akathisia Rating Scale, and EuroQoL (for quality of life). Multiple and logistic regression analyses were applied. RESULTS: No significant difference in drug attitude was found between psychotic and nonpsychotic patients. Our results showed a highly significant association between DAI and compliance (Spearman index, 0.33; P = 0.005); for all other variables, DAI associated significantly only with quality of life (r = 0.25; P = 0.03). The multivariable analysis confirmed the presence of a strong association between compliance and DAI (P =

KW - Adolescence

KW - Antipsychotic drugs

KW - Compliance

KW - Drug Attitude Inventory (DAI)

KW - Psychosis

KW - Subjective experience

UR - http://www.scopus.com/inward/record.url?scp=84891748856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891748856&partnerID=8YFLogxK

U2 - 10.1097/JCP.0000000000000035

DO - 10.1097/JCP.0000000000000035

M3 - Article

C2 - 24145219

AN - SCOPUS:84891748856

VL - 34

SP - 99

EP - 108

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 1

ER -